RxDoctor Payments Data
★ My doctorsLook up a doctor →

Khalid Jabboury

Houston, TXNPI 1629064308

Payments from drug & device makers

$1,575in general payments, 2019–2025

Across 80 payments — averaging $19.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$265
  • Johnson & Johnson$196
  • AstraZeneca$170
  • Merck$98
  • Boehringer Ingelheim$91
  • Seagen Inc.$89
  • plus $666 from 23 others

What the payments were for

  • Food & beverage$1,32484%
  • Education$25016%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer20$265
Johnson & Johnson8$196
AstraZeneca8$170
Merck5$98
Boehringer Ingelheim4$91
Seagen Inc.2$89
Amgen4$76
GSK2$58
Tempus AI, Inc2$48
Gilead2$47
Array Biopharma Inc2$43
Lilly USA, LLC2$37
Astellas Pharma US Inc2$36
Genentech USA, Inc.2$29
Jazz Pharmaceuticals Inc.1$29
Blueprint Medicines Corporation1$27
Stemline Therapeutics Inc.1$27
Daiichi Sankyo Inc.1$26
E.r. Squibb & Sons, L.L.C.1$22
Mirati Therapeutics, Inc.1$21
Sanofi1$19
EMD Serono, Inc.1$18
Secura Bio, Inc.1$17
Ipsen Biopharmaceuticals, Inc1$16
Takeda Pharmaceuticals U.S.A., Inc.1$16
Rigel Pharmaceuticals, Inc.1$15
Eisai Inc.1$14
Taiho Oncology, Inc.1$13
Myovant Sciences Inc.1$11

Where these figures come from

Is this you, or does something look wrong? →